Share >  
Share
Share on Tumblr

Zydus Pharmaceuticals (usa) Inc

News »

   latest by relevance
Glenmark gets tentative US FDA nod for asthma drug
Nov 28, 2011 at 14:21 | Source: Moneycontrol.com
Glenmark Generics Inc USA has received tentative approval from US Food and Drugs Administration for Montelukast Sodium 10 mg tablets, a generic version of pharma major Merck's Singulair tablets.
Glenmark Generics gets US FDA nod for hypertension drug
Aug 04, 2011 at 09:36 | Source: Moneycontrol.com
Glenmark Generics Inc USA, the unit of Glenmark Generics, has received final approval from the US Food and Drugs Administration (FDA) for its abbreviated new drug application (ANDA) to market its Verapamil extended-release tablets, which are indicated for management of essential hypertension.
Glenmark gets USD 15m plant upgradation advance from Salix
Jul 26, 2011 at 13:54 | Source: PTI
Glenmark Pharmaceuticals today said it has received USD 15 million (over Rs 65 crore) from Salix Pharmaceuticals Inc, USA, as an advance payment to upgrade its plant for production of Crofelemer, used for treating diarrhoea.
Promius Pharma buys US rights of Cloderm cream
Apr 03, 2011 at 12:08 | Source: PTI
Promius Pharma LLC, an arm of Dr Reddy's Laboratories, today said it has bought the USA marketing rights of Cloderm (clocortolone pivalate 0.1%) cream manufactured by Canada-based Valeant Pharmaceuticals International, Inc.
Piramal Glass cons revenues grow 44% to Rs 2.7bn
Jan 20, 2009 at 19:02
Piramal Glass Limited consolidated revenues grow 44% to Rs. 2.7 billion, Operating Profit (excluding FOREX impact) up by 35% to Rs. 430 million
Glenmark to mkt Levetiracetam tablets for US mkt
Jan 16, 2009 at 17:20
Glenmark Generics Inc., USA (GGI), the subsidiary of Glenmark Generics Limited (GGL), has today commenced marketing and distribution of Levetiracetam 250 mg, 500 mg and 750 mg tablets in the U.S. market.

Videos »
Abbott India has target of Rs 630: G Shah
more »

Photos »

  /  
Related News »
Entry into a Material Definitive Agreement, Change in Directors or Principal Officers
On May 9, 2012, the Company filed a lawsuit in the United States District Court for the District of New Jersey against Zydus Pharmaceuticals (USA) Inc., ("Zydus Inc.") and Cadila Healthcare Limited ("Cadila") (collectively "Zydus") for infringement of U.S ...
May 18, 2012 at 10:14 | Source: Yahoo! Finance

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window